MYCOSES is a renowned academic journal published by Wiley, specializing in the fields of Dermatology, Infectious Diseases, and general Medicine, with a commendable focus on mycological research and its clinical implications. Established in 1957, this journal has significantly contributed to advancing our understanding of fungal diseases, offering a platform for high-quality research that ranks among the top in its categories—achieving Q1 status in Dermatology and Q1 in Medicine (miscellaneous), while maintaining a strong Q2 ranking in Infectious Diseases. With an impressive Scopus ranking of #5 in Medicine - Dermatology, MYCOSES occupies a pivotal position in the dissemination of critical findings and innovative practices within the scientific community. Although it is not an open-access journal, MYCOSES continues to attract a wide array of researchers, professionals, and students seeking to enhance their knowledge and keep abreast of the latest developments in mycology. Overall, MYCOSES not only serves as an essential resource for academia but also plays a vital role in shaping future research directions and clinical approaches to fungal infections.

Bone & Joint Open, an esteemed journal published by the British Editorial Society of Bone & Joint Surgery, represents a significant advancement in the dissemination of research in the field of orthopedics and sports medicine. With an E-ISSN of 2633-1462, this Open Access journal has been providing unrestricted access to high-quality research since its inception in 2020, making it a pivotal resource for researchers, clinicians, and students alike. The journal boasts an impressive Q1 ranking in both Orthopedics and Sports Medicine and Surgery categories, affirming its impact and relevance in an increasingly competitive academic landscape. Furthermore, it ranks #81 out of 551 in the discipline of Medicine Surgery and #66 out of 321 in Orthopedics and Sports Medicine, reflecting its high standards of publication and contribution to the field. Located in the heart of the United Kingdom, Bone & Joint Open aims to facilitate the exchange of innovative research and critical advancements, ensuring that all stakeholders have access to essential findings that drive the evolution of surgical practices and orthopedic care.

ORTHOPEDIC CLINICS OF NORTH AMERICA, published by W B Saunders Co-Elsevier Inc., is a leading peer-reviewed journal in the field of orthopedics and sports medicine, established in 1970 and continuing to be influential through 2024. With an ISSN of 0030-5898 and an E-ISSN of 1558-1373, it is recognized for its rigorous academic standards, achieving a Q2 ranking in the 2023 Scopus category for orthopedics and sports medicine, placing it in the 67th percentile among its peers. This journal provides a comprehensive range of scholarly articles, clinical studies, and reviews designed to advance orthopedic knowledge and enhance patient care. While the journal currently does not offer open access options, it remains accessible to professionals, researchers, and students who seek to stay updated with the latest advancements and trends in orthopedics. By disseminating critical research findings and clinical insights, ORTHOPEDIC CLINICS OF NORTH AMERICA plays a vital role in shaping the future of orthopedic practice and education.

Frontiers in Cellular and Infection Microbiology, published by FRONTIERS MEDIA SA, is a leading Open Access journal that has been at the forefront of microbiological research since 2011. Located in Switzerland, this journal aims to provide a platform for innovative and impactful studies in various domains including immunology, infectious diseases, and medical microbiology. With an impressive range of quartile rankings—Q1 in Infectious Diseases, Microbiology, and Microbiology (medical), and Q2 in Immunology—as of 2023, it positions itself as a highly reputable source in the academic community. Furthermore, its Scopus rankings highlight its significance within the respective fields, with top percentiles in key categories, making it an essential resource for researchers, professionals, and students alike. As an Open Access publication, it ensures that vital findings are accessible to a global audience, fostering collaboration and advancement in science.

The JOURNAL OF ORTHOPAEDIC RESEARCH, published by WILEY, stands as a premier peer-reviewed journal in the field of orthopedics and sports medicine, showcasing high-impact research with a notable impact factor and categorized in the top Q1 quartile for 2023. Since its inception in 1983, this journal has continuously evolved to meet the needs of a dynamic scientific community, serving as a vital resource for researchers, clinicians, and students engaged in the study and practice of orthopedics. With commendable rankings, positioned at Rank #47 out of 321 in the Medicine Orthopedics and Sports Medicine category, and boasting a remarkable 85th percentile in Scopus rankings, it highlights groundbreaking studies and advances in orthopedic science. While not an open-access journal, it provides diverse access options to ensure that its contributions are available to a broad academic audience. The journal plays a crucial role in disseminating innovative ideas and fostering collaboration within the orthopedic research community, thereby promoting improved patient care and outcomes in musculoskeletal health.

The JOURNAL OF SHOULDER AND ELBOW SURGERY, published by MOSBY-ELSEVIER, is a premier peer-reviewed journal dedicated to advancing the field of shoulder and elbow surgery. With an impressive impact factor that underscores its influence—ranking in the Q1 quartile across several categories including Medicine, Orthopedics and Sports Medicine, Sports Science, and Surgery—the journal presents high-quality research that informs clinical practices and enhances patient outcomes. Since its inception in 1992 and running continuously through 2024, it serves as an essential resource for researchers, clinicians, and students interested in the latest developments in surgical techniques, rehabilitation, and innovative treatments. Though it does not currently offer open access, the journal is highly regarded for its robust editorial standards and comprehensive coverage of topics pertinent to upper extremity surgery, ensuring its readers are well-equipped with the latest insights and methodologies. Located in New York, NY, this publication continues to push the boundaries of knowledge and practice in the rapidly evolving health care landscape.

Urologia Journal, with ISSN 0391-5603 and E-ISSN 1724-6075, is a pivotal publication in the field of urology, published by SAGE Publications Ltd. Established in the United States, the journal has a rich historical foundation, with coverage spanning various periods beginning in 1947 and continuing to the present day, indicating its commitment to chronicling advancements in urological research and practice. As of 2023, the journal has achieved a respectable Q3 ranking in the field of Urology, reflecting its increasing influence and relevance among academic peers. Though not an open-access journal, it provides substantial value to its readers with rigorous peer-reviewed content that enhances the understanding and treatment of urological conditions. Researchers, clinicians, and students are encouraged to engage with the Urologia Journal to keep abreast of the latest findings and methodologies that contribute to better patient care and innovative therapeutic options in urology. As the field evolves, Urologia Journal remains committed to promoting quality scholarship and disseminating vital knowledge that shapes the future of urology.

Surgical Infections, published by MARY ANN LIEBERT, INC, is an esteemed journal dedicated to advancing the understanding and management of infections associated with surgical procedures. With an ISSN of 1096-2964 and an E-ISSN of 1557-8674, this journal has emerged as a vital resource within the fields of Infectious Diseases, Surgery, and Microbiology. Over the years, it has established a notable presence, achieving a 2023 Q2 ranking in Infectious Diseases and Surgery, as well as a Q3 ranking in Microbiology. The journal holds an impressive position at 74th percentile in Surgery according to Scopus, making it a reliable platform for disseminating current research and clinical practices. Surgical Infections aims to provide an interdisciplinary forum for both seasoned professionals and academics, encouraging the exploration of novel therapeutic approaches, prevention strategies, and case studies that address the complexities of surgical-related infections. As the field continues to evolve, this journal remains committed to fostering innovative research that enhances clinical outcomes and patient safety.

The Revista Espanola de Quimioterapia, published by the SOCIEDAD ESPANOLA QUIMIOTERAPIA, is a pivotal open-access journal that has been advancing the field of clinical microbiology and pharmacology since its inception in 1989. With an E-ISSN of 1988-9518, this journal caters to a diverse audience of researchers, healthcare professionals, and students, providing them with critical insights into the latest developments in medicinal chemistry and therapeutic strategies. Located in Madrid, Spain, the journal reflects the rigorous academic standards of its associated institutions, contributing significantly to the translation of research into clinical practice. Achieving a Q3 ranking in the fields of Medicine, Microbiology, and Pharmacology in 2023 attests to its growing influence and relevance in the scientific community, making it a vital resource for those engaged in the quest for innovative solutions to pressing healthcare challenges. The journal prides itself on its commitment to maintaining an open-access model since 2018, ensuring that vital research is freely accessible to foster greater knowledge sharing and collaboration within the global scientific community.

Medical Mycology Journal is a leading publication in the field of medical mycology, dedicated to advancing the understanding and treatment of fungal infections. Published by the Japanese Society of Medical Mycology, this journal serves as an essential resource for researchers, clinicians, and students alike. With an ISSN of 2185-6486 and an E-ISSN of 2186-165X, it aims to provide high-quality peer-reviewed articles focusing on clinical and epidemiological studies, diagnosis, and novel therapeutic approaches related to fungal pathogens. Operating under a Q3 ranking in Infectious Diseases and having consistently published significant findings since its establishment in 2011, the journal is pivotal for those working at the intersection of mycology and infectious disease management. Although currently non-open access, the journal's insights are vital for expanding knowledge in this critical area of healthcare, addressing pressing global health challenges linked to fungal infections.